Avalo Therapeutics, Inc. ( NASDAQ:AVTX – Get Rating ) major shareholder Caissa Capital Management Ltd. bought 7,000 shares of the business's stock in a transaction that occurred on Monday, May 22nd. The stock was purchased at an average price of $3.34 per share, with a total value of $23,380.00. Following the completion of the purchase, the insider now directly owns 1,373,700 shares in the company, valued at approximately $4,588,158. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website .

https://www.dailypolitical.com/2023/05/22/avalo-therapeutics-inc-nasdaqavtx-major-shareholder-purchases-23380-00-in-stock.html

#dailypolitical